Misonix, Inc.
- Jurisdiction
United States - LEI
529900HG50MXZLNDT534 - ISIN
US6048711039 (MSON )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
5
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
4
/ 7
Profile
Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally. Read full profile
Stock price
Fundamentals
- Net revenue
€63.14M - Gross margin
71.1% - EBIT
-€9.41M - EBIT margin
-14.9% - Net income
-€12.35M - Net margin
-19.6%
Statement period: - (published )
Dividends
No dividend payouts
Earnings Calls
Latest earnings call: May 9, 2021